4//SEC Filing
Ryan Michael Charles 4
Accession 0001104659-21-098784
CIK 0001792581other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 3:05 PM ET
Size
7.4 KB
Accession
0001104659-21-098784
Insider Transaction Report
Form 4
Ryan Michael Charles
Chief Technology Officer
Transactions
- Other
Common Stock
2021-07-13+50,189→ 50,189 total - Other
Restricted Stock Units
2021-07-12+31,991→ 31,991 total→ Common Stock (31,991 underlying)
Footnotes (3)
- [F1]The securites were acquired pursuant to a Membership Interest Purchase Agreement dated as of June 14, 2021 among Kiromic Biopharma, Inc., InSilico Solutions, LLC and Michael Ryan.
- [F2]Each restricted stock unit is the economic equivalent of one share of Kiromic Biopharma, Inc. common stock.
- [F3]The vesting schedule is such that 25% of the RSUs vest on June 30, 2022, and the remainder will vest at a rate of 1/36th per month for 36 months thereafter.
Documents
Issuer
Kiromic Biopharma, Inc.
CIK 0001792581
Entity typeother
Related Parties
1- filerCIK 0001875002
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 3:05 PM ET
- Size
- 7.4 KB